‘Having the Violence Leave’: Women’s Experiences of the ‘Safe at Home’ Programme

2016 ◽  
pp. 138-155
Author(s):  
Angela Hartwig
Keyword(s):  
Women’S Experiences ◽  
Women's Experiences ◽  
At Home

scholarly journals Women’s experiences of self-administration of misoprostol at home as part of early medical abortion: a qualitative evaluation

2020 ◽  
pp. bmjsrh-2020-200661 ◽  
Author(s):  
Jeni Harden ◽  
Julie Ancian ◽  
Sharon Cameron ◽  
Nicola Boydell
Keyword(s):  
Clinical Setting ◽  
Qualitative Interviews ◽  
Qualitative Evaluation ◽  
Medical Abortion ◽  
Self Administration ◽  
Women’S Experiences ◽  
Women's Experiences ◽  
The Uk ◽  
Experiences Of Women ◽  
At Home

BackgroundBetween 2017 and 2019, legislation was introduced in the UK that approved the home as a place for self-administration of misoprostol for early medical abortion. While research has shown that early medical abortion at home is as safe as in a clinical setting, women’s experiences in the UK in the light of this change have not yet been investigated. This qualitative research explored the experiences of women in one region of Scotland, UK who accessed early medical abortion with home self-administration of misoprostol.MethodsQualitative interviews were conducted with 20 women who had recently undergone early medical abortion (≤69 days' gestation) with home self-administration of misoprostol. The data were analysed thematically using an approach informed by the Framework analytic approach.ResultsWomen appreciated the flexibility that home administration of misoprostol offered, including the opportunity to control the timing of the abortion. This was particularly important for women who sought not to disclose the abortion to others. Most women valued being in the comfort and privacy of the home when preparing for self-administration, although a small number highlighted some concerns about being at home. Most women reported that self-administration of misoprostol was straightforward; however, some expressed concerns around assessing whether their experiences were ‘normal’.ConclusionsWomen welcomed the opportunity for home self-administration of misoprostol. To further improve women’s early medical abortion experience we suggest that the legislation be amended so that women can self-administer in an appropriate non-clinical setting, not just their home.

Women's experiences of having an early medical abortion at home

2016 ◽  
Vol 9 ◽  
pp. 48-54 ◽  
Author(s):  
Maria Hedqvist ◽  
Lina Brolin ◽  
Tanja Tydén ◽  
Margareta Larsson
Keyword(s):  
Medical Abortion ◽  
Women’S Experiences ◽  
Women's Experiences ◽  
At Home

scholarly journals Self-management of overactive bladder at home using transcutaneous tibial nerve stimulation: a qualitative study of women’s experiences

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Ciara M. E. Daly ◽  
Lynette Loi ◽  
Jo Booth ◽  
Dalia Saidan ◽  
Karen Guerrero ◽  
...  
Keyword(s):  
Overactive Bladder ◽  
Nerve Stimulation ◽  
Tibial Nerve ◽  
Feasibility Trial ◽  
Self Management ◽  
Women’S Experiences ◽  
Women's Experiences ◽  
Tibial Nerve Stimulation ◽  
Hospital Clinic ◽  
At Home

Abstract Background Transcutaneous tibial nerve stimulation (TTNS) has been used to treat overactive bladder (OAB), however patient experiences and views of this treatment are lacking. The aim of this study was to explore women’s experiences of OAB and TTNS treatment and the perceived factors influencing participation and adherence. Methods Semi-structured, individual interviews conducted as part of a mixed-methods, randomised, feasibility trial of self-managed versus HCP-led TTNS. Interviews were audio recorded and transcribed verbatim. Reflexive thematic analysis was undertaken using Booth et al. (Neurourol Urodynam. 2017;37:528–41) approach. Results 16 women were interviewed, 8 self-managing TTNS at home and 8 receiving TTNS in twice-weekly hospital clinic appointments. Women self-managing OAB considered TTNS easy to administer, flexible and favourably ‘convenient’, especially when the participant was bound by work and other life commitments. In contrast to OAB symptoms ‘dominating life’, self-managing bladder treatment was empowering and fitted around home life demands. Flexibility and control engendered by self-management, facilitated women’s willingness to participate in TTNS. Women attending a hospital clinic for TTNS enjoyed the social aspects but found the routine appointments constrained their lives. Motivation to continue TTNS in the longer term was dependent on perception of benefit. Conclusions This study provides novel insights into women’s experiences of self-managing their OAB using TTNS compared to HCP-led management in the clinical setting. It highlights positive experiences self-managing TTNS at home and a willingness to continue in the longer term, facilitated by ease of use and convenience. Trial Registration 1/11/2018: ClinicalTrials.gov Identifier: NCT03727711.

scholarly journals Women’s experiences and acceptability of medical termination of pregnancy

2019 ◽  
Vol 33 (2) ◽  
pp. 127-137
Author(s):  
Kittipong Saejeng ◽  
Unnop Jaisamrarn ◽  
Wanapa Naravage
Keyword(s):  
Family Planning ◽  
Reproductive Health ◽  
Termination Of Pregnancy ◽  
Serious Adverse Events ◽  
Content Type ◽  
Women’S Experiences ◽  
Medical Termination Of Pregnancy ◽  
Women's Experiences ◽  
Medical Termination ◽  
At Home

Purpose The purpose of this paper is to understand women’s experiences, acceptability and outcomes of using the medical termination of pregnancy (MTP). The study is conducted at nine reproductive health and family planning clinics at university hospitals as well as regional and provincial hospitals located in Bangkok and the locations within Thailand. Design/methodology/approach This is a descriptive research recruiting healthy women with pregnancy up to 63 days since the last menstrual period (LMP) who opted for MTP during 2012–2014. Findings A total of 443 women who were referred from the reproductive health networks voluntarily participated in the study. Overall, 92.6 percent of participants had a complete abortion. No serious adverse events were found for cases using misoprostol at home or at clinic. More than 98.3 percent of the women felt satisfied or very satisfied with the method. More than 80 percent of participants thought that the side-effects of the method were as expected or less than expected. More than 95 percent of the women recommended having MTP available in Thailand. Originality/value The introduction of MTP that uses a mifepristone and misoprostol regimen (Medabon®) in pregnancies up to 63 days, since LMP demonstrates that misoprostol can be safely used by women at home or at clinic. The administration of misoprostol at home reduces the number of hospital visits, which saves time and costs for traveling from home to the facility. In addition, women have more privacy and control over their bodies by self-administering misoprostol. The MTP’s introductory results also show that MTP service provision is well integrated into reproductive health and family planning services. It is useful for stakeholders who would be involved in design and planning of health system services before the MTP is made broadly available throughout the country.

Women's Experiences at Cervical Screening

1995 ◽  
Vol 40 (3) ◽  
pp. 81-82 ◽  
Author(s):  
I.K. Crombie ◽  
S. Orbell ◽  
G. Johnston ◽  
A.J. Robertson ◽  
M. Kenicer
Keyword(s):  
Cervical Screening ◽  
Recent Experience ◽  
Smear Test ◽  
Women’S Experiences ◽  
Cervical Smears ◽  
Women's Experiences ◽  
Almost All ◽  
Unpleasant Experience ◽  
Test Result ◽  
At Home

Concerns about attendance for cervical screening has focussed on determining the reasons why some women never attend. Less attention has been paid to whether women continue to attend for further smears, although this is essential for further screening. This study investigated woemn's experiences of cervical screening and their views on subsequent attendance. Three hundred and thirty nine women aged 20–64 were identified from a computerised register of cervical smears as having had a smear test within the previous three years. They were interviewed at home about their most recent experience of screening. Just over half of the women (53%) recalled being anxious before the test, and about one fifth reported embarrassment (19%) or pain (20%) during it. The frequencies of discomfort were higher amongst those who were anxious about the test, athough 24% of those who were embarrassed and 28% who had pain reported being unconcerned beforehand. The frequencies of pain and embarrassment were only slightly higher when the smear taker was male. Many women (22%) reported being concerned about the test result although only 10% of those who were concerned were recalled for further assessment. Although a number of women had unpleasant experiences, almost all (95%) who were under 60 years of age said they were likely to attend for a subsequent smear. Taking cervical smears is often an unpleasant experience for women, although some of the distressing events could easily have been avoided. Attention to technique and to the concerns of individual patients, especially ensuring privacy, could reduce the extent of the problem. The uptake of subsequent smears should be monitored to ensure that women are not being discouraged from attendance.

A provoking choice—Swedish women's experiences of reactions to their plans to give birth at home

2012 ◽  
Vol 25 (3) ◽  
pp. e11-e18 ◽  
Author(s):  
Ingela Sjöblom ◽  
Ewa Idvall ◽  
Ingela Rådestad ◽  
Helena Lindgren
Keyword(s):  
Women’S Experiences ◽  
Women's Experiences ◽  
At Home
Sign in / Sign up

Export Citation Format

Share Document